North America MRSA Drugs Market Set for Steady Growth Through 2034
Across North America, the growing burden of antibiotic-resistant infections is increasing the focus on effective MRSA prevention, diagnosis, and treatment. Greater awareness of antimicrobial resistance, continued incidence of healthcare-associated infections, and demand for advanced therapeutic options are encouraging pharmaceutical companies to invest in innovative antimicrobial solutions....
0 Reacties 0 aandelen 39 Views 0 voorbeeld